Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …

Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients
with coronary artery disease, and an even higher proportion of those with heart failure (HF) …

Background: Iron deficiency is common in heart failure and associated with worse outcomes.
We examined the prevalence and consequences of iron deficiency in the DAPA-HF trial …

Iron is an essential micronutrient for a myriad of physiological processes in the body beyond
erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure …

In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Aims Iron deficiency (ID) is common in heart failure (HF) and linked with poor prognosis
regardless of anaemia. We assessed temporal trends in ID testing, ID prevalence, ID …

Non-anaemic iron deficiency (NAID) is a strategic target in cardiovascular medicine because
of its association with a range of adverse effects in various conditions. Endeavours to tackle …

Iron deficiency (ID) in conjunction with heart failure (HF) poses a challenge for clinicians and
is associated with worse HF outcomes. Treatment of ID with IV iron supplementation for …

Background Reduced kidney function is common among patients with heart failure. In
patients with heart failure and/or kidney disease, iron deficiency is an independent predictor …

Iron deficiency is a significant comorbidity of heart failure (HF), defined as the inability of the
myocardium to provide sufficient blood flow. However, iron deficiency remains insufficiently …